Bacterial communities of female genital tract have impact on inflammation, HIV risk

May 19, 2015, Massachusetts General Hospital
An HIV-infected cell. Credit: NIAID

A team led by researchers from Massachusetts General Hospital (MGH) and the Ragon Institute of MGH, MIT and Harvard has found that the most common bacterial community in the genital tract among healthy South Africa women not only is significantly different from that of women in developed countries but also leads to elevated levels of inflammatory proteins. In a paper in the May 19 issue of Immunity, the investigators describe finding potential mechanisms by which particular bacterial species induce inflammation and show that the presence of those species and of elevated levels of inflammatory proteins could increase the risk of HIV infection.

"Ours is the first study to identify a specific bacterial community in the genital tract of healthy that is highly pro-inflammatory, and we show this community is common in the women we studied in South Africa," says Douglas Kwon, MD, PhD, of the Ragon Institute and the MGH division of Infectious Diseases, senior author of the report. "We also identified specific mechanisms by which the senses these and potential mechanisms linking that response to increased HIV susceptibility."

The authors note that, although inflammatory reactions in the female genital tract can prevent or eliminate many , activation of the immune system paradoxically increases the risk that exposure to HIV will lead to infection. In the past, the bacterial population of the female tract was believed to be very simple and - based on what was seen in white, premenopausal women - dominated by a single Lactobacillus species. Since mild vaginal infections that alter the dominant microbial community can increase the risk of acquiring HIV and other sexually transmitted diseases, the researchers designed the current study to investigate whether differences in the genital microbial communities of healthy women might affect overall susceptibility to infection.

Analysis of genital samples from a group of 94 young black South African women - who were HIV negative and had no disease symptoms - revealed that only a minority had the sort of Lactobacillus-dominant bacterial communities commonly seen in U.S. women. The researchers grouped the samples they studied into four community types - what they called cervicotypes - based on the dominant bacterial species. The most common cervicotype among the study participants was very diverse, with low levels of Lactobacillus and no single dominant bacterial group.

To assess levels of immune activation in the study participants, the researchers measured levels of the immune system signaling molecules called cytokines in vaginal fluid samples and found significant individual differences - as much as 1,000-fold in some cases. Elevated cytokines were not associated with active sexually transmitted infections or with factors such as sexual frequency or the use of condoms or hormonal contraceptives. Comparing cytokine levels among the cervicotypes revealed that the low-Lactobacillus, high-diversity communities were more than four times as likely to have elevated genital inflammatory cytokines. In fact, the presence of community was a better predictor of inflammation than was the presence of or other vaginal infections.

The researchers found that women with the highest levels of genital inflammation also had elevated levels of CCR5+ CD4+ T cells, the cells that are infected by HIV, in their genital tracts. "It has been shown that having a higher frequency of these HIV target cells at the site of exposure increases the risk of infection," says study lead author Melis Anahtar, an MD/PhD candidate in the Harvard/MIT Division of Health Sciences and Technology. "It's possible that treatments targeting specific genital bacteria could improve the effectiveness of measures - such as antiretroviral vaginal gels - designed to prevent HIV infection. In addition, finding that women with elevated genital inflammation may be three times more likely to become HIV-infected suggests that generally targeting the genital microbial population may further reduce risk."

An assistant professor of Medicine at Harvard Medical School, Kwon adds, "Understanding the impact of differences in the genital microbial population could also have implications for pregnant women and their infants. Some of the pro-inflammatory species that we found in our study were originally found in infected amniotic fluid and may contribute to the risk for premature birth and other complications of pregnancy." The research team is now investigating the specific mechanisms by which the immune system senses the presence of specific bacterial species in the female as well as examining the potential role of the broader microbial population, including viruses and fungi.

Explore further: Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV

Related Stories

Bacterial vaginosis is associated with higher risk of female-to-male transmission of HIV

June 26, 2012
An investigation led by UCSF has found that the risk of female-to-male HIV transmission is increased three fold for women with bacterial vaginosis, a common disorder in which the normal balance of bacteria in the vagina is ...

Sexually transmitted co-infections increase HIV risk: study

June 20, 2011
(Medical Xpress) -- Bacterial and viral sexually transmitted infections can exacerbate HIV replication in co- infected individuals, a team of Canadian researchers led by Charu Kaushic, associate professor of pathology and ...

New worldwide estimates for herpes simplex virus type 2 published

January 23, 2015
New global estimates for herpes simplex virus type 2 show that over 400-million people worldwide were infected with the virus in 2012. The estimates underline the extent to which herpes simplex virus type 2 – the virus ...

Oral cancer-causing HPV may spread through oral and genital routes

November 12, 2014
Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and/or genital HPV infection, suggesting that the transmission of HPV occurs via oral-oral and oral-genital routes, according ...

Genital-only screening misses many cases of gonorrhea and chlamydia in women

April 28, 2015
Current public health guidelines recommend that only gay men and people with HIV should be routinely screened for extragenital gonorrhea and chlamydia, given the high burden of these sexually transmitted infections (STIs) ...

Recommended for you

Researchers find latent HIV reservoirs inherently resistant to elimination by CD8+ T-cells

January 22, 2018
The latest "kick-and-kill" research to eliminate the HIV virus uncovered a potential obstacle in finding a cure. A recent study by researchers at the George Washington University (GW) found that latent HIV reservoirs show ...

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.